PMC:7306567 / 14406-15327 JSONTXT

{"project":"LitCovid-PD-FMA-UBERON","denotations":[{"id":"T19","span":{"begin":850,"end":855},"obj":"Body_part"}],"attributes":[{"id":"A19","pred":"fma_id","subj":"T19","obj":"http://purl.org/sig/ont/fma/fma63083"}],"text":"Use of corticosteroids\nCorticosteroids should not be given to influenza patients as their use may be associated with increased risk of IAPA [7, 37–39]. A recent Cochrane review on this topic concluded that the use of corticosteroids in patients with influenza was associated with a worse outcome [40]. However, the evidence was almost exclusively observational. Furthermore, patients are often given steroids in the first few days preceding or after ICU admission for a variety of reasons including COPD exacerbation or complications such as sepsis. With surveys suggesting that approximately half of the physicians are not aware of IAPA [24], many physicians may additionally not be aware of the potential drawbacks of corticosteroids. Whenever the use of corticosteroids is unavoidable, more efforts (bronchoscopy with GM detection in BAL fluid or serum β-D-glucan test) should be made to exclude or diagnose IAPA [41]."}

{"project":"LitCovid-PD-UBERON","denotations":[{"id":"T17","span":{"begin":850,"end":855},"obj":"Body_part"}],"attributes":[{"id":"A17","pred":"uberon_id","subj":"T17","obj":"http://purl.obolibrary.org/obo/UBERON_0001977"}],"text":"Use of corticosteroids\nCorticosteroids should not be given to influenza patients as their use may be associated with increased risk of IAPA [7, 37–39]. A recent Cochrane review on this topic concluded that the use of corticosteroids in patients with influenza was associated with a worse outcome [40]. However, the evidence was almost exclusively observational. Furthermore, patients are often given steroids in the first few days preceding or after ICU admission for a variety of reasons including COPD exacerbation or complications such as sepsis. With surveys suggesting that approximately half of the physicians are not aware of IAPA [24], many physicians may additionally not be aware of the potential drawbacks of corticosteroids. Whenever the use of corticosteroids is unavoidable, more efforts (bronchoscopy with GM detection in BAL fluid or serum β-D-glucan test) should be made to exclude or diagnose IAPA [41]."}

{"project":"LitCovid-PubTator","denotations":[{"id":"149","span":{"begin":400,"end":408},"obj":"Chemical"},{"id":"150","span":{"begin":821,"end":823},"obj":"Chemical"},{"id":"151","span":{"begin":856,"end":866},"obj":"Chemical"},{"id":"152","span":{"begin":499,"end":503},"obj":"Disease"},{"id":"153","span":{"begin":542,"end":548},"obj":"Disease"}],"attributes":[{"id":"A149","pred":"tao:has_database_id","subj":"149","obj":"MESH:D013256"},{"id":"A150","pred":"tao:has_database_id","subj":"150","obj":"MESH:C012990"},{"id":"A152","pred":"tao:has_database_id","subj":"152","obj":"MESH:D029424"},{"id":"A153","pred":"tao:has_database_id","subj":"153","obj":"MESH:D018805"}],"namespaces":[{"prefix":"Tax","uri":"https://www.ncbi.nlm.nih.gov/taxonomy/"},{"prefix":"MESH","uri":"https://id.nlm.nih.gov/mesh/"},{"prefix":"Gene","uri":"https://www.ncbi.nlm.nih.gov/gene/"},{"prefix":"CVCL","uri":"https://web.expasy.org/cellosaurus/CVCL_"}],"text":"Use of corticosteroids\nCorticosteroids should not be given to influenza patients as their use may be associated with increased risk of IAPA [7, 37–39]. A recent Cochrane review on this topic concluded that the use of corticosteroids in patients with influenza was associated with a worse outcome [40]. However, the evidence was almost exclusively observational. Furthermore, patients are often given steroids in the first few days preceding or after ICU admission for a variety of reasons including COPD exacerbation or complications such as sepsis. With surveys suggesting that approximately half of the physicians are not aware of IAPA [24], many physicians may additionally not be aware of the potential drawbacks of corticosteroids. Whenever the use of corticosteroids is unavoidable, more efforts (bronchoscopy with GM detection in BAL fluid or serum β-D-glucan test) should be made to exclude or diagnose IAPA [41]."}

{"project":"LitCovid-PD-MONDO","denotations":[{"id":"T71","span":{"begin":62,"end":71},"obj":"Disease"},{"id":"T72","span":{"begin":250,"end":259},"obj":"Disease"},{"id":"T73","span":{"begin":499,"end":503},"obj":"Disease"}],"attributes":[{"id":"A71","pred":"mondo_id","subj":"T71","obj":"http://purl.obolibrary.org/obo/MONDO_0005812"},{"id":"A72","pred":"mondo_id","subj":"T72","obj":"http://purl.obolibrary.org/obo/MONDO_0005812"},{"id":"A73","pred":"mondo_id","subj":"T73","obj":"http://purl.obolibrary.org/obo/MONDO_0005002"}],"text":"Use of corticosteroids\nCorticosteroids should not be given to influenza patients as their use may be associated with increased risk of IAPA [7, 37–39]. A recent Cochrane review on this topic concluded that the use of corticosteroids in patients with influenza was associated with a worse outcome [40]. However, the evidence was almost exclusively observational. Furthermore, patients are often given steroids in the first few days preceding or after ICU admission for a variety of reasons including COPD exacerbation or complications such as sepsis. With surveys suggesting that approximately half of the physicians are not aware of IAPA [24], many physicians may additionally not be aware of the potential drawbacks of corticosteroids. Whenever the use of corticosteroids is unavoidable, more efforts (bronchoscopy with GM detection in BAL fluid or serum β-D-glucan test) should be made to exclude or diagnose IAPA [41]."}

{"project":"LitCovid-PD-CLO","denotations":[{"id":"T93","span":{"begin":152,"end":153},"obj":"http://purl.obolibrary.org/obo/CLO_0001020"},{"id":"T94","span":{"begin":280,"end":281},"obj":"http://purl.obolibrary.org/obo/CLO_0001020"},{"id":"T95","span":{"begin":468,"end":469},"obj":"http://purl.obolibrary.org/obo/CLO_0001020"},{"id":"T96","span":{"begin":867,"end":871},"obj":"http://purl.obolibrary.org/obo/UBERON_0000473"},{"id":"T97","span":{"begin":917,"end":919},"obj":"http://purl.obolibrary.org/obo/CLO_0053794"}],"text":"Use of corticosteroids\nCorticosteroids should not be given to influenza patients as their use may be associated with increased risk of IAPA [7, 37–39]. A recent Cochrane review on this topic concluded that the use of corticosteroids in patients with influenza was associated with a worse outcome [40]. However, the evidence was almost exclusively observational. Furthermore, patients are often given steroids in the first few days preceding or after ICU admission for a variety of reasons including COPD exacerbation or complications such as sepsis. With surveys suggesting that approximately half of the physicians are not aware of IAPA [24], many physicians may additionally not be aware of the potential drawbacks of corticosteroids. Whenever the use of corticosteroids is unavoidable, more efforts (bronchoscopy with GM detection in BAL fluid or serum β-D-glucan test) should be made to exclude or diagnose IAPA [41]."}

{"project":"LitCovid-PD-CHEBI","denotations":[{"id":"T87","span":{"begin":7,"end":22},"obj":"Chemical"},{"id":"T88","span":{"begin":217,"end":232},"obj":"Chemical"},{"id":"T89","span":{"begin":400,"end":408},"obj":"Chemical"},{"id":"T90","span":{"begin":720,"end":735},"obj":"Chemical"},{"id":"T91","span":{"begin":757,"end":772},"obj":"Chemical"},{"id":"T92","span":{"begin":821,"end":823},"obj":"Chemical"},{"id":"T94","span":{"begin":837,"end":840},"obj":"Chemical"},{"id":"T95","span":{"begin":860,"end":866},"obj":"Chemical"}],"attributes":[{"id":"A87","pred":"chebi_id","subj":"T87","obj":"http://purl.obolibrary.org/obo/CHEBI_50858"},{"id":"A88","pred":"chebi_id","subj":"T88","obj":"http://purl.obolibrary.org/obo/CHEBI_50858"},{"id":"A89","pred":"chebi_id","subj":"T89","obj":"http://purl.obolibrary.org/obo/CHEBI_35341"},{"id":"A90","pred":"chebi_id","subj":"T90","obj":"http://purl.obolibrary.org/obo/CHEBI_50858"},{"id":"A91","pred":"chebi_id","subj":"T91","obj":"http://purl.obolibrary.org/obo/CHEBI_50858"},{"id":"A92","pred":"chebi_id","subj":"T92","obj":"http://purl.obolibrary.org/obo/CHEBI_74120"},{"id":"A93","pred":"chebi_id","subj":"T92","obj":"http://purl.obolibrary.org/obo/CHEBI_27680"},{"id":"A94","pred":"chebi_id","subj":"T94","obj":"http://purl.obolibrary.org/obo/CHEBI_64198"},{"id":"A95","pred":"chebi_id","subj":"T95","obj":"http://purl.obolibrary.org/obo/CHEBI_37163"}],"text":"Use of corticosteroids\nCorticosteroids should not be given to influenza patients as their use may be associated with increased risk of IAPA [7, 37–39]. A recent Cochrane review on this topic concluded that the use of corticosteroids in patients with influenza was associated with a worse outcome [40]. However, the evidence was almost exclusively observational. Furthermore, patients are often given steroids in the first few days preceding or after ICU admission for a variety of reasons including COPD exacerbation or complications such as sepsis. With surveys suggesting that approximately half of the physicians are not aware of IAPA [24], many physicians may additionally not be aware of the potential drawbacks of corticosteroids. Whenever the use of corticosteroids is unavoidable, more efforts (bronchoscopy with GM detection in BAL fluid or serum β-D-glucan test) should be made to exclude or diagnose IAPA [41]."}

{"project":"LitCovid-PD-GlycoEpitope","denotations":[{"id":"T13","span":{"begin":821,"end":823},"obj":"GlycoEpitope"}],"attributes":[{"id":"A13","pred":"glyco_epitope_db_id","subj":"T13","obj":"http://www.glycoepitope.jp/epitopes/EP0510"}],"text":"Use of corticosteroids\nCorticosteroids should not be given to influenza patients as their use may be associated with increased risk of IAPA [7, 37–39]. A recent Cochrane review on this topic concluded that the use of corticosteroids in patients with influenza was associated with a worse outcome [40]. However, the evidence was almost exclusively observational. Furthermore, patients are often given steroids in the first few days preceding or after ICU admission for a variety of reasons including COPD exacerbation or complications such as sepsis. With surveys suggesting that approximately half of the physicians are not aware of IAPA [24], many physicians may additionally not be aware of the potential drawbacks of corticosteroids. Whenever the use of corticosteroids is unavoidable, more efforts (bronchoscopy with GM detection in BAL fluid or serum β-D-glucan test) should be made to exclude or diagnose IAPA [41]."}

{"project":"LitCovid-PD-HP","denotations":[{"id":"T23","span":{"begin":499,"end":503},"obj":"Phenotype"},{"id":"T24","span":{"begin":542,"end":548},"obj":"Phenotype"}],"attributes":[{"id":"A23","pred":"hp_id","subj":"T23","obj":"http://purl.obolibrary.org/obo/HP_0006510"},{"id":"A24","pred":"hp_id","subj":"T24","obj":"http://purl.obolibrary.org/obo/HP_0100806"}],"text":"Use of corticosteroids\nCorticosteroids should not be given to influenza patients as their use may be associated with increased risk of IAPA [7, 37–39]. A recent Cochrane review on this topic concluded that the use of corticosteroids in patients with influenza was associated with a worse outcome [40]. However, the evidence was almost exclusively observational. Furthermore, patients are often given steroids in the first few days preceding or after ICU admission for a variety of reasons including COPD exacerbation or complications such as sepsis. With surveys suggesting that approximately half of the physicians are not aware of IAPA [24], many physicians may additionally not be aware of the potential drawbacks of corticosteroids. Whenever the use of corticosteroids is unavoidable, more efforts (bronchoscopy with GM detection in BAL fluid or serum β-D-glucan test) should be made to exclude or diagnose IAPA [41]."}

{"project":"LitCovid-sentences","denotations":[{"id":"T94","span":{"begin":0,"end":22},"obj":"Sentence"},{"id":"T95","span":{"begin":23,"end":151},"obj":"Sentence"},{"id":"T96","span":{"begin":152,"end":301},"obj":"Sentence"},{"id":"T97","span":{"begin":302,"end":361},"obj":"Sentence"},{"id":"T98","span":{"begin":362,"end":549},"obj":"Sentence"},{"id":"T99","span":{"begin":550,"end":736},"obj":"Sentence"},{"id":"T100","span":{"begin":737,"end":921},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"Use of corticosteroids\nCorticosteroids should not be given to influenza patients as their use may be associated with increased risk of IAPA [7, 37–39]. A recent Cochrane review on this topic concluded that the use of corticosteroids in patients with influenza was associated with a worse outcome [40]. However, the evidence was almost exclusively observational. Furthermore, patients are often given steroids in the first few days preceding or after ICU admission for a variety of reasons including COPD exacerbation or complications such as sepsis. With surveys suggesting that approximately half of the physicians are not aware of IAPA [24], many physicians may additionally not be aware of the potential drawbacks of corticosteroids. Whenever the use of corticosteroids is unavoidable, more efforts (bronchoscopy with GM detection in BAL fluid or serum β-D-glucan test) should be made to exclude or diagnose IAPA [41]."}

{"project":"LitCovid-PMC-OGER-BB","denotations":[{"id":"T109","span":{"begin":7,"end":22},"obj":"CHEBI:50858;CHEBI:50858"},{"id":"T110","span":{"begin":23,"end":38},"obj":"CHEBI:50858;CHEBI:50858"},{"id":"T111","span":{"begin":217,"end":232},"obj":"CHEBI:50858;CHEBI:50858"},{"id":"T112","span":{"begin":400,"end":408},"obj":"CHEBI:35341;CHEBI:35341"},{"id":"T113","span":{"begin":499,"end":503},"obj":"PR:000004197"},{"id":"T114","span":{"begin":720,"end":735},"obj":"CHEBI:50858;CHEBI:50858"},{"id":"T115","span":{"begin":757,"end":772},"obj":"CHEBI:50858;CHEBI:50858"},{"id":"T116","span":{"begin":841,"end":846},"obj":"UBERON:0006314"},{"id":"T117","span":{"begin":850,"end":855},"obj":"UBERON:0001977"},{"id":"T70117","span":{"begin":7,"end":22},"obj":"CHEBI:50858;CHEBI:50858"},{"id":"T48384","span":{"begin":23,"end":38},"obj":"CHEBI:50858;CHEBI:50858"},{"id":"T63590","span":{"begin":217,"end":232},"obj":"CHEBI:50858;CHEBI:50858"},{"id":"T32212","span":{"begin":400,"end":408},"obj":"CHEBI:35341;CHEBI:35341"},{"id":"T66911","span":{"begin":499,"end":503},"obj":"PR:000004197"},{"id":"T3164","span":{"begin":720,"end":735},"obj":"CHEBI:50858;CHEBI:50858"},{"id":"T20945","span":{"begin":757,"end":772},"obj":"CHEBI:50858;CHEBI:50858"},{"id":"T18373","span":{"begin":841,"end":846},"obj":"UBERON:0006314"},{"id":"T59301","span":{"begin":850,"end":855},"obj":"UBERON:0001977"}],"text":"Use of corticosteroids\nCorticosteroids should not be given to influenza patients as their use may be associated with increased risk of IAPA [7, 37–39]. A recent Cochrane review on this topic concluded that the use of corticosteroids in patients with influenza was associated with a worse outcome [40]. However, the evidence was almost exclusively observational. Furthermore, patients are often given steroids in the first few days preceding or after ICU admission for a variety of reasons including COPD exacerbation or complications such as sepsis. With surveys suggesting that approximately half of the physicians are not aware of IAPA [24], many physicians may additionally not be aware of the potential drawbacks of corticosteroids. Whenever the use of corticosteroids is unavoidable, more efforts (bronchoscopy with GM detection in BAL fluid or serum β-D-glucan test) should be made to exclude or diagnose IAPA [41]."}

{"project":"2_test","denotations":[{"id":"32572532-22895826-47963429","span":{"begin":141,"end":142},"obj":"22895826"},{"id":"32572532-21107529-47963430","span":{"begin":144,"end":146},"obj":"21107529"},{"id":"32572532-30076120-47963430","span":{"begin":144,"end":146},"obj":"30076120"},{"id":"32572532-31939808-47963431","span":{"begin":297,"end":299},"obj":"31939808"},{"id":"32572532-32160910-47963432","span":{"begin":639,"end":641},"obj":"32160910"},{"id":"32572532-29090327-47963433","span":{"begin":917,"end":919},"obj":"29090327"},{"id":"T84490","span":{"begin":141,"end":142},"obj":"22895826"},{"id":"T81142","span":{"begin":144,"end":146},"obj":"21107529"},{"id":"T94939","span":{"begin":144,"end":146},"obj":"30076120"},{"id":"T52886","span":{"begin":297,"end":299},"obj":"31939808"},{"id":"T42293","span":{"begin":639,"end":641},"obj":"32160910"},{"id":"T10315","span":{"begin":917,"end":919},"obj":"29090327"}],"text":"Use of corticosteroids\nCorticosteroids should not be given to influenza patients as their use may be associated with increased risk of IAPA [7, 37–39]. A recent Cochrane review on this topic concluded that the use of corticosteroids in patients with influenza was associated with a worse outcome [40]. However, the evidence was almost exclusively observational. Furthermore, patients are often given steroids in the first few days preceding or after ICU admission for a variety of reasons including COPD exacerbation or complications such as sepsis. With surveys suggesting that approximately half of the physicians are not aware of IAPA [24], many physicians may additionally not be aware of the potential drawbacks of corticosteroids. Whenever the use of corticosteroids is unavoidable, more efforts (bronchoscopy with GM detection in BAL fluid or serum β-D-glucan test) should be made to exclude or diagnose IAPA [41]."}